Qure Medical buys Tompkins Pharmaceutical Rubber

Bruce Meyer

Published: February 18, 2014 12:45 pm ET
Updated: February 18, 2014 12:47 pm ET

Related to this story

Topics Medical

Qure Medical of Twinsburg, Ohio, has bought Tompkins Pharmaceutical Rubber of South Plainfield, N.J., in a deal that will boost Qure's offerings to the pharmaceutical side of the medical business.

The unit of Twinsburg-based Q Holding Co. closed the deal Jan. 24 and sent out a letter that day to Tompkins customers saying Qure would work with them to make the transition period as seamless as possible.

Terms of the deal and how much revenue the Tompkins business posted last year were not disclosed.

"It was not a distressed bargain buy," said Randy Ross, Q Holding president. "The business has been well-managed. It's been performing successfully. But when the owners got through the whole process, they recognized it could be even better in our hands. You've got to pay for good technology and good companies, but it was worth it to us."

The Tompkins business has made rubber components for the pharmaceutical industry since 1908. It was bought by Itran Precision Rubber in late 1998; Itran closed the Tompkins plant in Blue Bell, Pa., and incorporated its production into the Itran factory in South Plainfield.

Over time the Tompkins production will be transferred to the Qure Medical plant in Rock Hill, S.C., according to Ross. The move will be made gradually as needed customer qualifications and approvals are gained because the Tompkins portfolio largely deals with components that are listed in Drug Master Files with the Food and Drug Administration.

"It's not a simple "pick it up and move it' in the sense that these are highly regulated markets, and these customers deal with life-saving and life-altering devices and medications," Ross said. "We want to move at a pace the customers are comfortable with and meets their needs."

The Itran business will continue to operate at the South Plainfield plant, Ross said.

Big step forward

Much of the Tompkins' processing technology is similar to what Qure has in place in Rock Hill, but the focuses of the businesses were different. Ross said Rock Hill concentrates more on the medical device side of the market with some business in the pharmaceutical sector, while Tompkins was more deeply involved in pharmaceuticals.

Much of Tompkins' products end up in drug delivery, where rubber stoppers are used in vials of drugs that are to be injected into somebody's body.

"This is where the Drug Master Files become so critical," Ross said. "Tompkins has a great history in that space of developing compounds that are inert relative to exposure to medicines they have to deliver."

Where Qure can help Tompkins improve is with its quality and processing systems, Ross said.

"We think we bring some things when you combine the two businesses because of our quality operating systems, clean room manufacturing and our disciplines," he said.

"Their strengths and our strengths will fit together to give people a great pharmaceutical supplier."

Ross concedes that West Pharmaceutical Services Inc. remains the dominant player in the sector, but believes Qure Medical is a strong No. 2 on the medical device side of the business, and the Tompkins acquisition makes it a "more meaningful competitor" on the pharmaceutical side.

The Tompkins purchase jumps Qure four or five years forward in material science than if it had to develop it on his own, the Q Holding CEO said.

"We believe the existing customers of Qure Medical will benefit from this because we can offer them a wider portfolio of products," Ross said.

"Similarly, a great group of customers that have been working with Tompkins will get the benefit of access to the wide variety of products that Qure Medical already offers."

A quest for completeness

Ross is open about Qure Medical's quest to be a more comprehensive supplier to its customers. It wants to deliver a wide variety of elastomer products from a wide range of geographic locations to its medical customers. He said many medical device makers have a supply chain that has grown too large, and that his firm can be a consolidator.

"I believe there is a trend toward narrowing that supply base down to a smaller group of larger suppliers," he said. "We think Qure Medical can deliver more products and technology in the elastomer space than anybody else in the medical or pharmaceutical business."

So Qure will continue to add to its technology and materials science competencies and expand its geographic reach, such as recent moves to produce components in China and distribute goods in Europe.

"It's really all about being the best possible supplier you can be to these customers and the belief that by doing more, we'll ultimately become the supplier of choice because they don't want to handle 100 different elastomer suppliers," Ross said.

That's why the Tompkins acquisition was a "no-brainer," Ross said.

"You could just see that they had such a complementary set of customers and technologies to Qure Medical, and at the same time Qure Medical could bring a lot of improvement opportunities to Tompkins Pharmaceutical," he said.


Qure Medical buys Tompkins Pharmaceutical Rubber

Bruce Meyer

Published: February 18, 2014 12:45 pm ET
Updated: February 18, 2014 12:47 pm ET

Post Your Comments

Back to story

More stories

Sumitomo Bakelite buying injection molder Vaupell Holdings

April 24, 2014 7:37 pm ET

Private equity firm H.I.G. Capital LLC of Miami has entered into a definitive agreement to sell plastics processor Vaupell Holdings Inc. to Sumitomo...    More

Zimmer buying Biomet in $13 billion deal

April 24, 2014 4:25 pm ET

Orthopedic device giant Zimmer Holdings Inc. is buying rival Biomet Inc. in a $13.35 billion cash and stock deal, the companies announced April 24.    More

Some medical devices could get faster approval with new FDA rules

April 22, 2014 7:41 pm ET

The U.S. Food and Drug Administration is proposing an expedited approval for medical devices for devices aimed at the diagnosis or treatment of...    More


Two Ohio groups team up to accelerate development of future medical devices

April 22, 2014 9:55 am ET

The Austen BioInnovation Institute in Akron and Cleveland-based design specialists Nottingham Spirk announced a strategic partnership that the two...    More

MGS buying N.Y. medical molding plant from Hospira

April 17, 2014 10:19 pm ET

MGS Manufacturing Group is purchasing the Buffalo, N.Y., injection molding facility and related product line of Hospira Inc., effective July 1. Terms ...    More

Market Reports

Market Data Book - Rankings & Lists

A one-stop download of Plastic News' exclusive annual lists and processor rankings containing essential data including sales, employees, end markets, materials and more.
EXCLUSIVE EXCEL FEATURE: full mailing address details for available plant locations.

Learn more

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report provides analysis and discussions of economic and political conditions, market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as strategies being implemented by thermoformed packaging companies. In addition, there are reviews of 25 leading thermoformers in the packaging segment, assessing their growth initiatives and performance metrics over 10 years.

Learn more

Mold Making and Tooling Review and Outlook 2014 North America

This report provides in-depth analysis of the mold and toolmaking market for North America, including discussions of trends, opportunities, threats, the latest developments in production and labor and equipment trends impacting moldmakers.

Learn more

Upcoming Plastics News Events

May 6, 2014 - May 8, 2014Plastics in Medical Devices 2014

May 12, 2014 - May 12, 2014Plastics News Brazil Pharma Summit

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

February 3, 2015 - February 7, 2015Plastics News Executive Forum 2015

More Events